首页> 外文OA文献 >Solubility Determination of Active Pharmaceutical Ingredients Which Have Been Recently Added to the List of Essential Medicines in the Context of the Biopharmaceutics Classification System–Biowaiver

【2h】

Solubility Determination of Active Pharmaceutical Ingredients Which Have Been Recently Added to the List of Essential Medicines in the Context of the Biopharmaceutics Classification System–Biowaiver

机译：溶解度测定最近在生物制冷分类系统 - BioWaiver的背景下添加到基本药物清单中的活性药物成分

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Gerlinde F. Plöger; Martin A. Hofsäss; Jennifer B. Dressman;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. [J] . Lindenberg M, Kopp S, Dressman JB European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V . 2004,第2期

机译：根据生物制药分类系统，在世界卫生组织基本药物模型清单中对口服药物的分类。
2. Biopharmaceutics classification system (BCS)-based biowaiver for immediate release solid oral dosage forms of moxifloxacin hydrochloride (Moxiflox GPO) manufactured by the Government Pharmaceutical Organization (GPO) [J] . Nawaphon Saelim, Khemjira Suksawaeng, Jutamat Chupan, Asian Journal of Pharmaceutical Sciences . 2016,第1期

机译：政府制药组织（GPO）生产的基于盐酸莫西沙星（Moxiflox GPO）的速释固体口服剂型的基于生物制药分类系统（BCS）的生物豁免
3. Biopharmaceutics classification system(BCS)-based biowaiver for immediate release solid oral dosage forms of moxifloxacin hydrochloride(Moxiflox GPO) manufactured by the Government Pharmaceutical Organization(GPO) [J] . Nawaphon Saelim, Khemjira Suksawaeng, Jutamat Chupan, 亚洲药物制剂科学(英文) . 2016,第001期

机译：基于生物制药分类系统（BCS）的生物豁免，由政府制药组织（GPO）生产的盐酸莫西沙星（Moxiflox GPO）速释固体口服剂型
4. Feasibility of Biowaiver for Biopharmaceutics Classification System Class III Drugs: Cimetidine [C] . Ekarat Jantratid, Sompol Prakongpan, Jennifer B. Dressman Annual meeting exposition of the Controlled Release Society . 2005

机译：生物制药分类系统III类药物的生物豁免的可行性：西咪替丁
5. Impact of polymers on the solution crystal growth rate of a poorly water-soluble active pharmaceutical ingredient. [D] . Schram, Caitlin J. 2015

机译：聚合物对水溶性差的活性药物成分的溶液晶体生长速率的影响。
6. Evaluation of the use of partition coefficients and molecular surface properties as predictors of drug absorption: a provisional biopharmaceutical classification of the list of national essential medicines of Pakistan [O] . R. Shawahna, NU. Rahman 2011

机译：评价使用分配系数和分子表面性质作为药物吸收的预测因子：巴基斯坦国家基本药物清单的临时生物制药分类
7. Biopharmaceutics classification system (BCS)-based biowaiver for immediate release solid oral dosage forms of moxifloxacin hydrochloride (Moxiflox GPO) manufactured by the Government Pharmaceutical Organization (GPO) [O] . Nawaphon Saelim, Khemjira Suksawaeng, Jutamat Chupan, 2016

机译：基于生物药剂学分类系统（BCs）的生物豁免，用于由政府药物组织（GpO）制造的盐酸莫西沙星（moxiflox GpO）的立即释放固体口服剂型

Solubility Determination of Active Pharmaceutical Ingredients Which Have Been Recently Added to the List of Essential Medicines in the Context of the Biopharmaceutics Classification System–Biowaiver

著录项

引文网络

相似文献

相关主题

期刊订阅